How Much Does Weight Loss Medication Cost in Australia?

by Burst Health
How Much Does Weight Loss Medication Cost in Australia?

The cost of prescription weight loss medication in Australia ranges from under $130 per month for some oral treatments to $700 or more per month for certain injectable medications at higher doses. But the medication itself is only part of the picture - consultations, monitoring, and complementary support all contribute to the real cost of treatment. 

This guide breaks down the costs involved in medically supervised weight management in Australia as of early 2026. Prices change over time and vary between pharmacies, so the figures here are based on current pharmacy pricing and should be treated as informed guidance rather than exact quotes. Your prescriber and pharmacist are the best sources for current pricing specific to your situation.

What Determines the Cost of Weight Loss Medication?

There is no single price for weight loss medication. The cost depends on several interconnected factors, and understanding these helps you plan realistically.

Type of Medication

Different classes of weight loss medication carry significantly different price points. Oral medications (appetite suppressants and lipase inhibitors) are generally at the lower end. Combination oral tablets sit in the mid-range. Injectable GLP-1 receptor agonists and dual-action receptor agonists are at the higher end.

To understand the different medication categories and how each works, see our guide to the types of weight loss medication available in Australia.

PBS Listing and Subsidies

Whether a medication is listed on the Pharmaceutical Benefits Scheme (PBS) has the single largest impact on what you pay at the pharmacy. The PBS is the Australian Government program that subsidises prescription medicine costs.

For PBS-listed medications, the maximum a general patient pays per script is the PBS co-payment - currently $25.00 as of January 2026 (reduced from $31.60). Concession card holders pay $7.70 per script, a rate frozen until 2029.

However, the reality for weight loss medication is that most options are not currently PBS-listed for the specific indication of weight management. Some medications are PBS-subsidised when prescribed for other conditions (such as type 2 diabetes), but the same medication prescribed for weight loss outside those criteria attracts the full private prescription price.

For full detail on PBS coverage for weight loss medications, see our guide to weight loss medication and the PBS in Australia.

Dose Level and Treatment Phase

Many weight loss medications, particularly injectables, require a gradual dose escalation over several weeks or months. During escalation, you are on a lower dose - and for injectable medications, this typically means a lower-cost pen. Once you reach the maintenance dose, the monthly cost increases.

This means the cost of month one may be significantly less than the cost of month six. When budgeting for treatment, it is important to understand the full cost trajectory, not just the starting price.

Pharmacy Pricing

In Australia, pharmacies set their own prices for private (non-PBS) prescriptions and may charge a dispensing fee on top of the medication cost. Prices for the same medication can vary meaningfully between pharmacies - online pharmacies, discount chemists, and standard pharmacies may all price differently. It is worth comparing prices, particularly for ongoing monthly purchases.

Medication Costs by Category (2026 Pricing)

The following cost ranges are based on current Australian pharmacy pricing for private prescriptions (without PBS subsidy). All figures are approximate monthly costs.

Oral Appetite Suppressants

Oral appetite suppressants that act on central nervous system pathways are among the lower-cost prescription options. Monthly costs typically range from approximately $90 to $160, depending on the specific medication and dose strength.

These medications are generally prescribed for shorter treatment periods (up to 12 weeks at a time), which limits the total outlay compared to longer-term treatments. Some are classified as Schedule 8, which means prescriptions are limited in quantity and require more frequent prescriber visits - an additional cost factor to consider.

Lipase Inhibitors

Lipase inhibitors that work by reducing dietary fat absorption are priced in the range of approximately $110 to $140 per month at private prescription pricing. These are taken with meals, typically three times daily.

Lipase inhibitors are one of the few weight loss treatments available without a doctor's prescription in Australia - the standard 120mg dose is classified as a Pharmacist Only Medicine (Schedule 3). Pharmacy pricing for the over-the-counter product is generally in the same range.

For eligible veterans and war widows, this medication category is listed on the Repatriation PBS (RPBS) at the concessional co-payment of $7.70.

Combination Oral Medications

Combination tablets that target multiple neurological pathways are priced at approximately $260 per month at the maintenance dose. This places them between the simpler oral options and injectable treatments in terms of cost.

Combination medications are not currently PBS-listed for weight management. The cost is consistent month to month once the maintenance dose is reached, though the dose escalation period in the first few weeks may use fewer tablets.

GLP-1 Receptor Agonist Injections

Injectable GLP-1 receptor agonist medications are among the most expensive category of weight loss treatment. Costs vary significantly depending on the dose level, because treatment involves gradual escalation from a starting dose to a maintenance dose over several months.

Based on current pharmacy pricing:

  • Starting doses (month 1-2): approximately $260 to $270 per month

  • Mid-escalation doses (months 3-4): approximately $250 to $270 per month

  • Higher escalation and maintenance doses: approximately $390 per month

Each pen device provides a one-month supply (four weekly doses). There is an important PBS development to note: in January 2026, the Pharmaceutical Benefits Advisory Committee (PBAC) recommended PBS listing for a GLP-1 receptor agonist used at the weight management dose, but only for patients with a BMI of 35 or above (or 32.5+ for certain populations) and established cardiovascular disease. Price negotiations between the government and manufacturer are ongoing, and no listing date has been confirmed. If listed, the cost would drop to $25.00 per script (or $7.70 for concession card holders) for eligible patients.

Dual-Action Receptor Agonist Injections (GLP-1/GIP)

The newest category of injectable treatment - dual-action receptor agonists targeting both GLP-1 and GIP receptors - carries the widest cost range because the dose spectrum is broader.

Based on current pharmacy pricing:

  • Starting dose (month 1): approximately $285 to $290 per month

  • Lower maintenance doses: approximately $400 to $425 per month

  • Mid-range doses: approximately $550 per month

  • Higher maintenance doses: approximately $690 to $700 per month

Most patients stabilise at a dose in the mid-range, meaning typical ongoing monthly costs sit between approximately $400 and $550. However, some patients require higher doses, which pushes the monthly cost toward $700.

Dual-action receptor agonists are not currently PBS-listed for weight management in Australia.

Monthly Cost Comparison at a Glance

The following summary gives a general sense of the monthly cost range for each medication category at private prescription prices:

  • Oral appetite suppressants: $90 to $160 per month (short-term use)

  • Lipase inhibitors: $110 to $140 per month

  • Combination oral medications: approximately $260 per month

  • GLP-1 receptor agonist injections: $260 to $390 per month (depending on dose phase)

  • Dual-action receptor agonist injections: $285 to $700 per month (depending on dose)

These figures represent the medication cost only. The sections below cover the additional costs that form part of the total investment in medically supervised weight management.

The Real 12-Month Cost: Beyond the Medication

Medication cost alone does not tell the full story. When planning financially for weight loss treatment, you should factor in several additional costs that are easy to overlook.

Medical Consultations

Obtaining a prescription requires a consultation with a registered medical practitioner. For ongoing treatment, your prescriber will need regular follow-up appointments - typically every four to twelve weeks - to monitor your response, assess side effects, and decide whether to continue, adjust, or cease treatment.

If your GP bulk-bills, there may be no out-of-pocket cost for standard consultations. However, many GPs charge a gap fee. A standard Level B consultation (approximately 20 minutes) typically costs between $80 and $100, with a Medicare rebate of approximately $41.20, leaving an out-of-pocket gap of roughly $40 to $60.

Specialist consultations (such as with an endocrinologist or obesity medicine physician) are significantly more expensive. Initial specialist consultations can exceed $300, with Medicare rebates covering only a portion.

Telehealth consultations are available for weight loss prescriptions and may have different fee structures. An important change from November 2025: Medicare rebates for telehealth consultations now require that the patient has seen the doctor or practice in person within the previous 12 months. For patients using telehealth-only services, this may mean that Medicare rebates do not apply, increasing the out-of-pocket cost.

Blood Tests and Pathology

Your doctor may order blood tests before starting treatment and at intervals during treatment to monitor your metabolic health, liver and kidney function, and other markers. Most standard pathology is covered by Medicare when ordered by a doctor, but some tests may attract a small gap fee (typically $5 to $30 per test). If you are seeing a non-bulk-billing doctor who orders pathology through a private laboratory, costs may be higher.

Sharps Disposal (Injectable Medications)

If you are using injectable medication, you will need a sharps container for used pen needles. Sharps containers are typically $5 to $15 from a pharmacy. Many Australian councils and pharmacies accept full sharps containers for free disposal. While this is a minor cost, it is a practical requirement of injectable treatment that should be factored in.

Allied Health Support

Weight loss medication is most effective when combined with dietary changes, physical activity, and behavioural support. Many patients choose to work with a dietitian, exercise physiologist, or psychologist as part of their weight management plan.

Under a GP Chronic Condition Management Plan (GPCCMP - which replaced the former GPMP from July 2025), up to five individual allied health sessions per calendar year are subsidised by Medicare. Your GP can prepare this plan if your weight management needs qualify as a chronic condition (which obesity generally does).

Medicare rebates for allied health sessions under a GPCCMP typically cover $50 to $60 per session. The full fee for a dietitian appointment, for example, may be $100 to $180, leaving a gap of $40 to $120 per session. Beyond the five Medicare-subsidised sessions, additional appointments are fully out-of-pocket.

What a 12-Month Budget Might Look Like

To illustrate the total cost picture, here is what a hypothetical 12-month treatment plan might cost across two different scenarios. These are illustrative only - actual costs depend on your specific medication, dosage, prescriber, and whether you access any subsidies.

Scenario A - Oral medication (appetite suppressant, 12-week course):

  • Medication (12 weeks at ~$130/month): approximately $390

  • Initial consultation + 2 follow-ups (gap ~$50 each): approximately $150

  • Blood tests (mostly Medicare-covered): approximately $20 to $50

  • Estimated total: approximately $560 to $590

Scenario B - Injectable GLP-1 receptor agonist (12-month ongoing treatment):

  • Medication (escalation + maintenance, averaging ~$340/month): approximately $4,080

  • Initial consultation + quarterly follow-ups (gap ~$50 each): approximately $250

  • Blood tests: approximately $50 to $100

  • Sharps disposal: approximately $20

  • 3 dietitian sessions (gap ~$80 each after Medicare): approximately $240

  • Estimated total: approximately $4,640 to $4,690

The difference between these two scenarios is substantial. This is why understanding the type of medication your doctor is considering, the expected treatment duration, and the full range of associated costs is important before starting treatment.

PBS Safety Net and Financial Supports

For patients who accumulate significant pharmaceutical spending in a calendar year, the PBS Safety Net provides additional support:

  • Once a general patient's PBS co-payments reach $1,748.20 in a calendar year (2026 threshold), subsequent PBS medications are provided at the concessional rate ($7.70) for the remainder of the year

  • Concession card holders who reach $277.20 in co-payments receive PBS medications at no cost for the rest of the year

It is important to note that the PBS Safety Net only applies to PBS-listed medications. If your weight loss medication is not PBS-subsidised (as is currently the case for most weight loss treatments), those costs do not count toward your Safety Net threshold. However, other PBS medications you take for different conditions do contribute, and reaching the threshold reduces costs across all your PBS prescriptions.

Private health insurance in Australia generally does not cover the cost of prescription medications dispensed through a pharmacy. Some policies may cover allied health consultations (dietitians, exercise physiologists) that form part of a weight management plan - check with your insurer.

Practical Ways to Manage Treatment Costs

While the cost of weight loss medication can be significant, particularly for injectable treatments, there are practical steps you can take:

  • Ask your prescriber about all available options - including whether a lower-cost medication category might be clinically appropriate for your situation

  • Compare pharmacy prices - particularly for private prescriptions, where pricing varies. Check both online pharmacies and local discount chemists

  • Understand the dose trajectory - ask your doctor to explain the escalation schedule and what the ongoing maintenance cost will be, not just the starting cost

  • Ask about PBS eligibility - if you have type 2 diabetes or other conditions, a medication that is PBS-listed for that condition may also support weight management at a subsidised price

  • Use a GPCCMP for allied health - ask your GP to prepare a Chronic Condition Management Plan so you can access Medicare-subsidised dietitian and exercise physiology sessions

  • Track your PBS spending - if you take multiple PBS medications, keep records to maximise the benefit of the Safety Net

  • Discuss treatment duration upfront - understand whether your doctor is recommending a short course (weeks) or ongoing treatment (months to years), and budget accordingly

Do not hesitate to discuss cost with your doctor. It is a legitimate clinical consideration, and your prescriber can factor it into their recommendation. A treatment plan you cannot sustain financially is not an effective treatment plan.

Frequently Asked Questions

Is weight loss medication covered by the PBS?

As of early 2026, most weight loss medications are not PBS-listed for the specific indication of weight management. The PBAC recommended PBS listing for one GLP-1 receptor agonist at the weight management dose in January 2026, but price negotiations are ongoing and no listing date is confirmed. Some medications are PBS-listed when prescribed for other conditions (such as type 2 diabetes), but prescribing them for weight loss outside those criteria means paying the full private price. Your prescriber can check whether any PBS pathway applies to your situation.

Why are injectable weight loss medications more expensive?

Injectable weight loss medications, particularly GLP-1 receptor agonists and dual-action agonists, are biologic or peptide-based treatments. They are significantly more complex to develop and manufacture than traditional small-molecule oral tablets. The delivery devices (pre-filled injection pens with dose mechanisms) also add to the cost. Additionally, many of these medications are still under patent protection, which prevents generic or biosimilar competition that would drive prices down.

Will prices come down in the future?

There are several developments that could reduce costs over time. PBS listing of injectable treatments would cap the patient cost at $25.00 per script for eligible patients. Patent expiry will eventually allow biosimilar versions of injectable medications to enter the market at lower prices. Oral formulations of GLP-1 receptor agonists are in late-stage clinical trials internationally, which could introduce lower-cost alternatives. However, timing for any of these developments remains uncertain.

Can I claim weight loss medication on tax?

The Australian tax offset for net medical expenses was phased out for most taxpayers in 2019. Some specific circumstances (such as disability-related expenses) may still be eligible for tax offsets. Consult a registered tax professional for advice relevant to your individual situation.

What if I cannot afford the medication my doctor recommends?

Tell your doctor. Cost is a valid clinical consideration, and your prescriber may be able to recommend an alternative medication category that achieves a reasonable outcome at a price point you can sustain. A treatment that you stop after two months because of cost will not deliver the same result as a less expensive treatment you can continue for six or twelve months. Your doctor can help find the right balance between clinical effectiveness and financial sustainability.

Back to Healthcare blog